NCT04063579View on ClinicalTrials.gov

Cardiac Magnetic Resonance Assessment for Heart Failure With Preserved Ejection Fraction

NACompletedINTERVENTIONAL
Enrollment

172

Participants

Timeline

Start Date

June 1, 2018

Primary Completion Date

September 29, 2021

Study Completion Date

December 31, 2021

Conditions
Heart Failure With Preserved Ejection Fraction
Interventions
DIAGNOSTIC_TEST

Cardiac Magnetic Resonance, Echocardiogram, Blood investigation (NT-proBNP), cardiac catheterization

Imaging, blood tests, LV pressure measurement

DIAGNOSTIC_TEST

Cardiac Magnetic Resonance, Echocardiogram, Blood investigation (NT-proBNP)

Imaging and Blood tests

Trial Locations (1)

Unknown

The University of Hong Kong, Hong Kong

All Listed Sponsors
lead

The University of Hong Kong

OTHER

NCT04063579 - Cardiac Magnetic Resonance Assessment for Heart Failure With Preserved Ejection Fraction | Biotech Hunter | Biotech Hunter